Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02629614 · ClinicalTrials.gov registry record · NA

Cala ONE Device for Essential Tremor

A NA study, sponsored by Cala Health.

Completed
Registry status
NA
Development phase
93
Enrollment target

NCT02629614 is a NA study that has completed, run by Cala Health. The registered enrollment target is 93 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02629614, a NA study, has completed, sponsored by Cala Health.

COMPLETED
Registry status
NA
Development phase
93 participants
Enrollment target

Study Summary

This study evaluates the safety and effectiveness of the Cala ONE device to aid in the symptomatic relief of hand tremors in adult essential tremor subjects. This study is a prospective, randomized, double-blinded, sham-controlled study.

Interventions

  • DEVICE Cala ONE Device

Trial Details

FieldValue
Enrollment Target 93 participants
Start Date 2016-04
Est. Completion 2016-11
Phase NA

Sponsor

Cala Health

6 total trials

What the Registry Record Tells You About NCT02629614

The ClinicalTrials.gov registry entry for NCT02629614 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cala Health, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Cala ONE Device is the first listed.

NCT02629614 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02629614 about?

NCT02629614 is a clinical study titled "Cala ONE Device for Essential Tremor". This study evaluates the safety and effectiveness of the Cala ONE device to aid in the symptomatic relief of hand tremors in adult essential tremor subjects. This study is a prospective, randomized, double-blinded, sham-controlled study.

What is the current status of trial NCT02629614?

This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2016-04. Estimated completion is 2016-11.

What interventions are being tested in trial NCT02629614?

The interventions under investigation include: Cala ONE Device (DEVICE).

Who is sponsoring clinical trial NCT02629614?

This trial is sponsored by Cala Health, which has 6 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.